ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

ClinicalTrials.gov ID: NCT05350072

Public ClinicalTrials.gov record NCT05350072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo Controlled, 2-arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's Syndrome (NEPTUNUS-1)

Study identification

NCT ID
NCT05350072
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
275 participants

Conditions and interventions

Interventions

  • Placebo Other
  • VAY736 Biological

Other · Biological

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 27, 2022
Primary completion
May 6, 2025
Completion
Jun 1, 2026
Last update posted
May 13, 2026

2022 – 2026

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Medvin Clinical Research Van Nuys California 91405
West Broward Rheumatology Associates Inc Tamarac Florida 33321
Indiana Univ School of Dentistry Indianapolis Indiana 46202
Ochsner Health System Baton Rouge Louisiana 70809
The John Hopkins Jerome L Greene Sjogren Baltimore Maryland 21224
Winthrop University Hospital Mineola New York 11501
Carolina Arthritis Associates Wilmington North Carolina 28401
STAT Research Inc Dayton Ohio 45402
Altoona Center for Clin Res Duncansville Pennsylvania 16635
Precision Comprehensive Research Colleyville Texas 76034
Metroplex Clinical Research Dallas Texas 75231
Baylor College Of Medicine Houston Texas 77030
Houston Rheumatology and Arthrit Katy Texas 77494

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05350072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05350072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →